Sutinen J, Yki-Järvinen H. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 292: E687-E692, 2007. First published October 24, 2006; doi:10.1152/ajpendo.00219.2006.-Highly active antiretroviral therapy (HAART) is associated with metabolic adverse events such as lipodystrophy in human immunodeficiency virus (HIV)-infected patients. The objective of the present study was to evaluate the effects of HAART-associated lipodystrophy on resting energy expenditure and caloric intake. In this cross-sectional study we compared resting energy expenditure (REE) and energy intake in 30 HAART-treated patients with lipodystrophy (HAARTϩLDϩ) with 13 HAARTtreated patients without lipodystrophy (HAARTϩLDϪ). REE was measured using indirect calorimetry, and energy intake was recorded as a 3-day diary of food intake. REE (5,180 Ϯ 160 vs. 4,260 Ϯ 150 J/min, P Ͻ 0.01) and also REE expressed per fat-free mass (86 Ϯ 1 vs. 78 Ϯ 2 J⅐kg fat-free mass Ϫ1 ⅐ min Ϫ1 , P Ͻ 0.01) were significantly higher in the HAARTϩLDϩ than the HAARTϩLDϪ group. Rate of lipid oxidation was significantly higher in the HAARTϩLDϩ than the HAARTϩLDϪ group. Total energy and fat intakes were significantly increased in the HAARTϩLDϩ compared with the HAARTϩLDϪ group. These results imply that HAART-associated lipodystrophy is associated with increased REE and lipid oxidation and with increased caloric and fat intake. calorimetry; respiratory quotient; lipoatrophy; buffalo hump HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) has improved the prognosis of human immunodeficiency virus (HIV)-infected patients (25). HAART is, however, associated with metabolic complications, including lipodystrophy, insulin resistance, and dyslipidemia (19). As a result of widespread use of HAART, HAART-associated lipodystrophy (HAL) has become by far the most prevalent form of human lipodystrophies (16).
than in healthy controls (6) . Among HIV-infected subjects, the prevalence of lipodystrophy was not associated with an increase in REE/FFM. However, in these studies lipodystrophic patients did not have significantly less subcutaneous fat compared with HAART-treated nonlipodystrophic patients (1, 6, 21, 31, 32, 43) . Thus whether patients with significantly reduced amounts of subcutaneous fat have an increase in REE/ FFM is still unknown. Furthermore, food intake has not been quantified in any study involving lipoatrophic patients. The aim of the current study was to evaluate the effects of HAL on both REE and energy intake by comparing two previously characterized groups of HIV-infected, HAART-treated patients with and without significant loss of subcutaneous fat.
MATERIALS AND METHODS

Subjects and Study Design
This is a cross-sectional study on energy metabolism in two groups of HIV-infected, HAART-treated patients, one group with (HAARTϩLDϩ) and the other group without lipodystrophy (HAARTϩLDϪ). As previously described, the patients were recruited from the outpatient clinic of the Helsinki University Central Hospital (29, (51) (52) (53) (54) 61) . All participants had to have been treated with combination antiretroviral therapy for at least 18 mo before enrollment and did not have any signs or symptoms of current opportunistic infections. Indirect calorimetry was performed and blood samples were drawn after an overnight fast.
HAARTϩLDϩ patients had self-reported symptoms of loss of subcutaneous fat with or without increased abdominal girth, breast size, or development of a buffalo hump. HAARTϩLDϪ patients had received antiretroviral therapy without developing symptoms of lipodystrophy. Both the presence and absence of lipodystrophy was confirmed by a single investigator before enrollment.
The purpose, nature, and potential risks of the study were explained to the patients before their written, informed consent was obtained. The protocol was approved by the ethics committee of the Helsinki University Central Hospital.
Methods
Indirect calorimetry. Respiratory gas exchange and REE were recorded for 40 min by indirect calorimetry using the Deltatrac metabolic monitor (Datex, Helsinki, Finland). Substrate oxidation rates and rates of energy expenditure were calculated from the gas exchange data as previously described (15, 60) .
Food intake and physical activity. The participants kept a 3-day diary of food and fluid intake on 2 days of normal working and 1 day off from work. The patients were instructed not to change their regular diet on the days of data recording. The quality of food intake recording was confirmed, and data analysis was performed by an experienced dietician who was unaware of the absence or presence of lipodystrophy of the participants. Food diaries were analyzed using NUTRICA software (version 3.0; Research Centre of the Social Insurance Institution, Helsinki, Finland). Patients were asked about their physical activity during a structured interview. Physical activity was classified as light, such as walking, or strenuous, defined as any activity making patients to be out of breath or to sweat.
Body composition. Total body fat mass and lean body mass were determined using BIA (BioElectrical Impedance Analyzer System model BIA-101A; RJL Systems, Detroit, MI). The volumes of intraabdominal and subcutaneous fat were measured using magnetic resonance imaging. A total of 16 T1-weighed transaxial scans extending from 8 cm above to 8 cm below the fourth and fifth lumbar interspace were analyzed (field of view, 375 ϫ 500 mm 2 ; slice thickness, 10 mm; breath-hold repetition time, 138.9 ms; echo time, 4.1 ms). Intraabdominal and subcutaneous fat volumes were quantified using image analysis software (Alice 3.0; Parexel, Waltham, MA). In our hands, the reproducibility of intra-abdominal and subcutaneous fat measurements performed on two separate occasions was 5 and 3% (coefficient of variation) (50) . Subscapular skin fold thickness (mean of triplicate measurements) was performed using Harpender calipers (John Bull British Indicators, West Sussex, UK).
Laboratory analyses. Serum free insulin concentrations were determined with radioimmunoassay (Phadeseph Insulin RIA; Pharmacia & Upjohn Diagnostics, Uppsala, Sweden) after precipitation with polyethylene glycol (13) . Plasma glucose concentrations were measured using a hexokinase method. Serum total and HDL cholesterol and triglyceride concentrations were measured using respective enzymatic kits from Roche Diagnostics with an autoanalyzer (Roche Diagnostics Hitachi 917; Hitachi, Tokyo, Japan). Serum free fatty acid (FFA) concentrations were measured using fluorometric assay (38) . Serum leptin concentrations were quantified by radioimmunoassay with a commercial kit (Human Leptin RIA kit; Linco Research, St. Charles, MO). Serum concentrations of tumor necrosis factor (TNF)-␣ and IL-6 were measured using commercial enzyme-linked immunoassays (Quantikine; R&D Systems, Minneapolis, MN). The HIV viral load was measured using the HIV-1 Monitor Test (Roche Diagnostics, Branchburg, NJ) with a detection limit of 50 copies/ml.
Statistical Analysis
The unpaired t-test was used to compare differences between the groups. Logarithmic transformation was performed on skewed data. Correlations were calculated using Spearman's rank correlation coefficient. Categorical variables were compared using Fisher's exact test. All data are given as means Ϯ SE. All calculations were performed using the Systat statistical package (version 10.0; Systat, Evanston, IL) or GraphPad Prism (version 3.0; GraphPad, San Diego, CA). A P value Ͻ0.05 was considered statistically significant.
RESULTS
HIV-Related Characteristics
The mean time since the diagnosis of HIV was 8.2 Ϯ 0.6 vs. 8.6 Ϯ 1.3 yr (not significant, NS) in the HAARTϩLDϩ compared with the HAARTϩLDϪ group. None of the patients had symptoms or signs of an acute opportunistic infection at the time of the study, but eight patients (27%) in the HAARTϩLDϩ and one patient (8%) in the HAARTϩLDϪ group (NS) had a history of a previous AIDS-defining illness. The groups were comparable regarding the viral load (1.87 Ϯ 0.15 vs. 1.65 Ϯ 0.25 log 10 copies/ml, HAARTϩLDϩ vs. HAARTϩLDϪ, NS), CD4 count (572 Ϯ 54 vs. 516 Ϯ 70 ϫ 10 6 /l, respectively, NS), and the duration of combination antiretroviral therapy (4.2 Ϯ 0.2 vs. 3.8 Ϯ 0.4 yr, respectively, NS). All participants in both groups were receiving nucleoside reverse transcriptase inhibitors as part of the combination therapy. Of the thymidine analogs, zidovudine was used by 7 patients (23%) in the HAARTϩLDϩ group and 10 patients (77%) in the HAARTϩLDϪ group (P Ͻ 0.01), whereas stavudine was used by 21 (70%) and 3 patients (23%), respectively (P Ͻ 0.01). Thirty-three percent of the patients in the HAARTϩLDϩ group and 38% of those in the HAARTϩLDϪ group (NS) used nonnucleoside reverse transcriptase inhibitors, and 73 and 69%, respectively (NS), used protease inhibitors.
Body Composition and Biochemical Characteristics
As previously described (29, (51) (52) (53) (54) 61) , the age, body mass index, and total body fat mass values were comparable between the HAARTϩLDϩ and the HAARTϩLDϪ groups. The HAARTϩLDϩ group had, however, significantly less subcutaneous fat (1,100 Ϯ 200 vs. 1,800 Ϯ 300 cm 3 , P Ͻ 0.05) and more intra-abdominal fat (1,900 Ϯ 200 vs. 900 Ϯ 300 cm 3 , P Ͻ 0.01) than the HAARTϩLDϪ group ( Table 1) . The HAARTϩLDϩ group also had higher fasting serum insulin and triglyceride concentrations and lower HDL cholesterol concentrations than the HAARTϩLDϪ group. Serum FFA concentrations were slightly but not significantly increased in the HAARTϩLDϩ group compared with the HAARTϩLDϪ group. Serum leptin concentration was not significantly different between the two groups. Serum TNF-␣ (1.6 Ϯ 0.1 vs. 1.5 Ϯ 0.2 pg/ml, HAARTϩLDϩ vs. HAARTϩLDϪ, NS) and IL-6 (2.2 Ϯ 0.3 vs. 1.9 Ϯ 0.6 pg/ml, respectively, NS) concentrations were not significantly different between the groups.
Energy Metabolism
REE (kJ/min) was 21%, REE adjusted for body weight was 13%, and REE adjusted for FFM was 11% greater in the HAARTϩLDϩ than the HAARTϩLDϪ group ( Table 2 ). The increase in energy expenditure also remained significant if women were excluded from the analysis (data not shown). REE (kJ/day) correlated closely with FFM in both groups (r ϭ 0.89, P Ͻ 0.0001 in the HAARTϩLDϩ group and r ϭ0.83, P ϭ 0.005 in the HAARTϩLDϪ group) (Fig. 1) . The respiratory quotient (RQ) was significantly lower in the HAARTϩLDϩ than the HAARTϩLDϪ group. The rate of lipid oxidation was significantly increased in the HAARTϩLDϩ compared with the HAARTϩLDϪ group.
Within the HAARTϩLDϩ group, serum FFA concentration was significantly correlated with the rate of lipid oxidation (r ϭ 0.40, P Ͻ 0.05) (Fig. 2) . Neither serum FFA concentrations nor lipid oxidation rates correlated with dietary fat intake among the lipodystrophic patients. Serum C-reactive protein, IL-6, or TNF-␣ concentrations did not correlate with REE expressed per kilogram of body weight or FFM.
Food Intake and Physical Activity
Total caloric intake was significantly higher in the HAARTϩLDϩ group compared with the HAARTϩLDϪ group (Table 3) . Both fat intake in grams and the proportion of fat of total energy intake were significantly increased in the HAARTϩLDϩ compared with the HAARTϩLDϪ group. All significant differences in dietary intake between the groups shown in Table 3 remained unchanged even if women were excluded from the analysis, with the exception of total energy intake, which did not remain statistically significant (9,730 Ϯ 380 vs. 8,300 Ϯ 810 kJ/day, HAARTϩLDϩ vs. HAARTϩLDϪ, P ϭ 0.09). Serum leptin concentrations did not correlate with daily energy intake. Light (6.9 Ϯ 0.8 vs.
5.7 Ϯ 2.3 h/wk, HAARTϩLDϩ vs. HAARTϩLDϪ, NS) and strenuous physical activity (2.4 Ϯ 0.7 vs. 2.7 Ϯ 0.8 h/wk, respectively, NS) was comparable between the groups.
DISCUSSION
In the present study, REE was significantly higher in HIVinfected, HAART-treated patients with lipodystrophy than in HIV-infected, HAART-treated patients without lipodystrophy. The higher dietary energy intake in the HAARTϩLDϩ group is consistent with the higher energy expenditure. Patients with HAL also had higher lipid oxidation rates in both relative and absolute terms than patients without lipodystrophy.
Since HIV-infection itself has been associated with higher REE (20, 24, 35) and HAART with a decrease in REE (42), we compared two groups of HIV-infected, HAART-treated patients, one group with and the other without lipodystrophy. This comparison makes it possible to differentiate between effects of lipodystrophy from those of HIV infection and HAART per se. However, although all patients in the current study were using HAART, their antiretroviral combinations were not identical. Therefore, the possibility cannot be fully excluded that the differences in patients' antiretroviral regimens may have contributed to the differences in energy metabolism between the groups also by a direct drug-induced effect, which was not mediated by lipodystrophy. The use of different control groups, such as HIV-negative subjects or HIV-positive but untreated patients, may explain some of the discrepancies in the literature, such as a decreased REE in patients with HAL compared with HIV-infected but untreated patients (58) . In this comparison, the observed difference may not exclusively reflect a decrease in REE in HAL but also an increase in REE in the control group due to untreated HIV infection (6, 24) . A few previous studies have examined effects of HAL on REE. However, none of the previous studies has compared significantly lipoatrophic HAL patients with nonlipodystrophic HAART-treated patients, which may explain some of the differences in results. Our findings are in keeping with those by Kosmiski et al. (31) , who found a higher REE expressed per FFM in protease inhibitor (PI)-treated patients with lipodystrophy compared with that in PI-and non-PI-treated nonlipodystrophic patients (31) . These data contrast the results of three studies which found no difference in REE between lipodystrophic and weight-stable, nonlipodystrophic HIV-infected patients (1, 7, 43) . In another study by Kosmiski et al. (32) , total energy expenditure (TEE) consisting of REE, postprandial thermogenesis, and physical activity was higher in patients with HAL compared with HAART-treated patients without HAL and HIV-negative subjects. The increase in TEE could be attributed to an increase in REE (32) .
Thyroid hormones and catecholamines increase REE (12, 17, 48) . These hormones were not measured in the current study, but the patients had no signs or symptoms suggestive of excess production of either hormone, i.e., the patients were clinically euthyroid, and blood pressures and heart rates were comparable between the groups ( Table 1 ). The available data do not suggest that hyperthyroidism would be a contributor to higher REE in HAL. In a cohort of 350 HIV-infected subjects, hypo-rather than hyperthyroidism was the most common form of thyroid dysfunction, and HAL was not associated with thyroid function abnormalities (8) . In a study comparing patients with HAL to HAART-treated patients without lipodystrophy, thyroid hormone concentrations were normal and similar in both groups (43) . However, the same study reported increased 24-h urinary catecholamine concentrations, which correlated with total resting metabolic rate in patients with HAL (43) . A limitation of this study is that REE was not expressed per FFM. Another study has found increased plasma norepinephrine but not epinephrine concentrations in HAARTtreated lipodystrophic patients compared with untreated HIVinfected patients (58) . However, the same study reported a decrease in REE adjusted for lean body mass in patients with HAL independent of increased plasma norepinephrine concentration (58) . The latter finding argues against a role for catecholamines in the etiology of increased REE in patients with HAL.
Increased circulating concentrations of proinflammatory cytokines TNF-␣ and IL-6 have been associated with hypermetabolism in AIDS patients with acute opportunistic infections (55) . In the present study, serum IL-6 or TNF-␣ concentrations did not differ between the HAARTϩLDϩ and HAARTϩLDϪ groups, and their concentrations did not correlate with REE. However, systemic concentrations of inflammatory cytokines may not reflect their action in target tissues. It therefore remains possible that increased local inflammation, as has been demonstrated in lipoatrophic adipose tissue (5, 26, 29, 34) , may contribute to increased energy expenditure.
In vitro, nucleoside analog reverse transcriptase inhibitors are known to inhibit mitochondrial DNA polymerase ␥ (28), and this has been suggested to be the underlying mechanisms for HAL (9) . Mitochondrial DNA is reduced in lipoatrophic adipose tissue in patients with HAL (47, 59 ) and also in individual human adipocytes (40) , which appears to impair mitochondrial function (22) . It was recently shown that during standardized exercise, mitochondrial dysfunction indeed characterizes patients with HAL (10). In the latter study, a rapid increase in lactic acid concentration, an impairment in the activities of respiratory chain enzymes, and mitochondrial histoenzymatic abnormalities were observed during exercise in skeletal muscle in patients with HAL (10) . Hypothetically, therefore, reduced efficacy of the respiratory chain to produce ATP may contribute to increased oxygen consumption in patients with HAL.
Another hypothetical mitochondrion-related cause for increased energy demand in HAL is an increase in the number of heat-producing brown fat cells. Uncoupling protein 1 (UCP-1) is exclusively expressed in brown adipocytes and is required for heat production. In rodents, interscapular and perirenal fat depots contain mainly brown adipocytes (23) . In healthy adult humans, there are no specific brown fat depots, but occasional brown adipocytes can be detected within normal white adipose tissue (23) . Interestingly, development of buffalo hump (19) and, more recently, increased perirenal fat mass (3) have been described as part of HAL syndrome. Increased UCP-1 gene expression has been demonstrated in HAL-associated buffalo humps compared with UCP-1 expression in subcutaneous adipose tissue from control subjects (44) . In the current study, patients with HAL had significantly thicker subscapular skin folds than the HAARTϩLDϪ group. Therefore, an increased number of heat-producing brown adipocytes could contribute to the higher REE observed in patients with HAL. On the other hand, it can be hypothesized that patients with significant lipoatrophy loose more heat through radiation due to the lack of an insulating subcutaneous fat layer apart from the shoulder area.
Another possibility that could contribute to the higher REE in patients with HAL is futile triglyceride/fatty acid cycling. Rates of lipolysis have been found to be elevated in patients with HAL compared with HIV-negative subjects (46) . The increased rate of lipolysis was associated with higher plasma concentrations of glycerol, palmitate, and total FFA (46) . An increased shuttling of fatty acids together with breakdown and reassembly of triglycerides consumes considerable amounts of energy. It has been estimated that as much as one-half of the prolonged increase in O 2 consumption after physical exercise may be consumed for triglyceride/fatty acid cycling in healthy adults (4) .
In addition to higher REE, we also found a significantly reduced RQ in the patients with HAL, implying higher oxidation of lipids relative to that of carbohydrates. Lipid oxidation was also higher in absolute terms in the HAARTϩLDϩ group. This finding is consistent with the data of Sekhar et al. (46) , who reported increased whole body fatty acid oxidation in patients with HAL compared with healthy controls. On the other hand, Kosmiski et al. (31) did not observe a difference in RQ when comparing patients with HAL to those without HAL.
The cause for the increased lipid oxidation in the HAARTϩLDϩ group cannot be determined in this crosssectional study. High FFA concentrations may promote lipid oxidation via mass action. In the current study, the HAARTϩLDϩ group tended to have higher FFA concentra-tions than the HAARTϩLDϪ group, but the difference did not reach statistical significance. Several other studies have reported significantly increased FFA concentrations in patients with HAL (37, 46, 57) . The significant positive correlation between fasting serum FFA concentration and lipid oxidation rate among patients with HAL is in keeping with this possibility (Fig.  2 ). In the current study, both absolute and relative dietary fat intake was increased in the HAARTϩLDϩ group, which could contribute to the increased lipid oxidation rate (45, 49) .
The HAARTϩLDϩ group had significantly higher dietary energy intake than the HAARTϩLDϪ group. This is an expected finding in the view of the higher energy expenditure but stable body weight. Leptin is a known regulator of satiety and food intake in mice, but its role as a satiety factor in humans is controversial (2, 27 ). In the current study, serum leptin concentrations were somewhat decreased in the HAARTϩLDϩ group compared with the HAARTϩLDϪ group, although the difference was not statistically significant. In non-HIV-lipodystrophic patients with severe hypoleptinemia, leptin treatment has decreased energy intake and REE (36, 41) . However, the role of leptin in HAL is not clear: HAL has been associated with decreased (14) , unchanged (11, 39) , and even increased (30) leptin concentrations. Therefore, it seems unlikely that slightly decreased leptin concentration in the HAARTϩLDϩ group would drive the observed hyperphagia in the current study. Increased ghrelin concentrations in patients with non-HIV lipodystrophy have been suggested to contribute to increased energy intake (36) . This is, again, an unlikely explanation for the higher food intake in the current study, since ghrelin concentrations have been decreased and not increased in patients with HAL (33) . One simple possibility for the increased food and fat intake in patients with HAL is patients' conscious or unconscious attempt to compensate for the fat atrophy.
In conclusion, REE was significantly higher in HIV-infected patients with HAART-associated lipodystrophy compared with HIV-infected HAART-treated patients who had not developed lipodystrophy, implying that lipodystrophy per se is associated with increased energy expenditure. Lipid oxidation is favored over carbohydrate oxidation in these patients. Both increased REE and lipid oxidation are linked with increased food and fat intake in patients with HAL.
